225 related articles for article (PubMed ID: 12669466)
1. Improving DNA vaccine potency via modification of professional antigen presenting cells.
Hung CF; Wu TC
Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
[TBL] [Abstract][Full Text] [Related]
2. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
Hung CF; Yang M; Wu TC
Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccines for cancer.
Boyd D; Hung CF; Wu TC
IDrugs; 2003 Dec; 6(12):1155-64. PubMed ID: 14666426
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization].
Deng X; Cai M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):175-9. PubMed ID: 12744193
[TBL] [Abstract][Full Text] [Related]
5. DNA vaccines--challenges in delivery.
Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
7. The processing of antigens delivered as DNA vaccines.
Howarth M; Elliott T
Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
[TBL] [Abstract][Full Text] [Related]
8. New tools for antigen delivery to the MHC class I pathway.
Morón G; Dadaglio G; Leclerc C
Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
[TBL] [Abstract][Full Text] [Related]
9. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming.
Ulmer JB; Otten GR
Dev Biol (Basel); 2000; 104():9-14. PubMed ID: 11713829
[TBL] [Abstract][Full Text] [Related]
10. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
11. Virosomes for antigen and DNA delivery.
Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
Fredriksen AB; Sandlie I; Bogen B
Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
[TBL] [Abstract][Full Text] [Related]
13. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
14. Naked antigen-presenting molecules on dendritic cells.
Davoust J; Banchereau J
Nat Cell Biol; 2000 Mar; 2(3):E46-8. PubMed ID: 10707098
[TBL] [Abstract][Full Text] [Related]
15. Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.
Tsen SW; Paik AH; Hung CF; Wu TC
Expert Rev Vaccines; 2007 Apr; 6(2):227-39. PubMed ID: 17408372
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses.
McKay PF; Barouch DH; Santra S; Sumida SM; Jackson SS; Gorgone DA; Lifton MA; Letvin NL
Eur J Immunol; 2004 Apr; 34(4):1011-20. PubMed ID: 15048711
[TBL] [Abstract][Full Text] [Related]
17. Targeting plasmid-encoded proteins to the antigen presentation pathways.
Leifert JA; Rodriguez-Carreno MP; Rodriguez F; Whitton JL
Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in antigen processing and presentation.
Jensen PE
Nat Immunol; 2007 Oct; 8(10):1041-8. PubMed ID: 17878914
[TBL] [Abstract][Full Text] [Related]
19. The cross-priming pathway: a portrait of an intricate immune system.
Basta S; Alatery A
Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation to naive CD4 T cells in the lymph node.
Itano AA; Jenkins MK
Nat Immunol; 2003 Aug; 4(8):733-9. PubMed ID: 12888794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
